Related Experiment Video

Updated: May 14, 2026

Constructing Cyclic Peptides Using an On-Tether Sulfonium Center
07:11

Constructing Cyclic Peptides Using an On-Tether Sulfonium Center

Published on: September 28, 2022

Synthesis, characterization and Akt phosphorylation inhibitory activity of cyclopentanecarboxylate-substituted

Md Maqusood Alam1, Eun-Ha Joh, Hyerim Park

  • 1Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 130-701, Republic of Korea.

Bioorganic & Medicinal Chemistry
|February 19, 2013
PubMed

Insights

Novel alkylphosphocholines show potent anticancer activity by inhibiting Akt phosphorylation. Compound 5b demonstrated significant cytotoxicity across multiple human cancer cell lines, highlighting its therapeutic potential.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Molecular Biology

Background:

  • Akt signaling pathway is frequently activated in human cancers, promoting tumor growth, proliferation, and survival.
  • Targeting the Akt pathway presents a promising strategy for developing novel anticancer therapies.

Purpose of the Study:

  • To synthesize and evaluate novel alkylphosphocholines with modified phospholipid head groups for Akt phosphorylation inhibitory activity.
  • To assess the cytotoxic effects of these compounds against human cancer cell lines (A549, MCF-7, KATO III).

Main Methods:

  • Synthesis of novel alkylphosphocholine derivatives incorporating cyclopentanecarboxylate.
  • In vitro evaluation of Akt phosphorylation inhibitory activity and IC50 values.
  • Cytotoxicity assays against A549, MCF-7, and KATO III cancer cell lines.

Main Results:

  • Compounds 5a, 5b, and 6c showed potent Akt phosphorylation inhibition (IC50: 3.1, 2.0, 3.0 μM), outperforming reference drugs.
  • Most synthesized compounds exhibited superior growth inhibition against A549 cells compared to reference drugs.
  • Compound 5b displayed remarkable cytotoxicity across A549, MCF-7, and KATO III cell lines.

Conclusions:

  • The novel alkylphosphocholines effectively inhibit Akt phosphorylation and exhibit potent anticancer activity.
  • Cytotoxic effects of these compounds are correlated with their Akt phosphorylation inhibitory potential.
  • Compound 5b is a promising candidate for further investigation in anticancer drug development.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...